Rhythmic properties of neurons in the rostral ventrolateral medulla of the rat in vitro: Effects of clonidine

Journal of Neurophysiology

Volumn 88, Issue 5, 2002, Pages 2262-2279

  Granata, Antonio R ^a,b,c   Cohen, Morton I ^a,b,c  

^a Department of Psychiatry ^*  (United States)

^b NEW YORK MEDICAL COLLEGE   (United States)

^c ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLONIDINE; RAUWOLSCINE; YOHIMBINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN SLICE; CELL POPULATION; CONTROLLED STUDY; DEPOLARIZATION; DRUG EFFECT; HYPERPOLARIZATION; IN VITRO STUDY; IN VIVO STUDY; INTRACELLULAR RECORDING; MALE; MEDULLA OBLONGATA; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; RAT; SPIKE; SYMPATHETIC TONE;

EID: 0036847885     PISSN: 00223077     EISSN: None     Source Type: Journal    
DOI: 10.1152/jn.00085.2002     Document Type: Article

References (48)

1. Allen AM and Guyenet PG. α2-Adrenoceptor-mediated inhibition of bulbospinal barosensitive cells of rat rostral medulla. Am J Physiol 34: R1065-R1075, 1993.
2. Barman SM and Gebber GL. Axonal projection patterns of ventrolateral medullospinal sympathoexcitatory neurons. J Neurophysiol 53: 1551-1566, 1985.
3. Barman SM and Gebber GL. "Rapid" rhythmic discharges of sympathetic nerves: Sources, mechanisms of generation, and physiological relevance. J Biol Rhythms 15: 365-379, 2000.
4. Bendat JS and Piersol AG. Random Data. Analysis and Measurement Procedures, 2nd Ed. New York: Wiley, 1986.
5. Christakos CN, Cohen MI, Barnhardt R, and Shaw C-F. Fast rhythms in phrenic motoneuron and nerve discharges. J Neurophysiol 66: 674-687, 1991.
6. Clement ME and McCall RB. Effects of clonidine on sympathoexcitatory neurons in the rostral ventrolateral medulla. Brain Res 550: 353-357, 1991.
7. Ernsberger P, Giuliano R, Willette RN, and Reis DJ. Role of imidazole receptors in the vasodepressor response to clonidine analogs in the rostral ventrolateral medulla. J Pharmacol Exp Ther 253: 408-418, 1990.
8. Ernsberger P, Graves ME, Graff LM, Zakieh N, Nguyen P, Collins LA, Westbrooks KL, and Johnson GG. I1-imidazoline receptors: Definition, characterization, distribution and transmembrane signaling. Ann NY Acad Sci 763: 22-42, 1995.
9. Ernsberger P, Meeley MP, Mann JJ, and Reis DJ. Clonidine binds to imidazoline binding sites as well as α2-adrenoceptors in the ventrolateral medulla. Eur J Pharmacol 134: 1-13, 1987.
10. Granata AR. Catecholaminergic mechanisms involved in the inhibition of pacemaker-like type II neurons in the rostral ventrolateral medulla (RVLM) in vitro. Soc Neurosci Abstr 20: 1181, 1994.
11. Granata AR. Electrophysiological and anatomical characterization of barosensitive neurons in the rostral ventrolateral medulla. In: Ventral Brain-stem Mechanisms and Control of Respiration and Blood Pressure, edited by Trouth CO, Millis RM, Kiwull-Schone H, and Schlafke ME. New York: Marcel Dekker, 1995, pp 837-871.
12. Granata AR and Kitai ST. Intracellular analysis in vivo of different barosensitive bulbospinal neurons in the rat rostral ventrolateral medulla. J Neurosci 12: 1-20, 1992.
13. Granata AR, Numao Y, Kumada M, and Reis DJ. A1 noradrenergic neurons tonically inhibit sympathoexcitatory neurons of C1 area in rat brainstem. Brain Res 377: 127-146, 1986.
14. Harrison JK, D'Angelo DD, Zeng DW, and Lynch KR. Pharmacological characterization of rat α2-adrenergic receptors. Mol Pharmacol 40: 407-412, 1991.
15. Hayar A and Guyenet PG. Prototypical imidazoline-1 receptor ligand moxonidine activates alpha2-adrenoceptors in bulbospinal neurons of the RVLM. J Neurophysiol 83: 766-776, 2000.
16. Hieble JP and Kolpak DC. Mediation of the hypotensive action of systemic clonidine in the rat by alpha2-adrenoceptors. Br J Pharmacol 110: 1635-1639, 1993.
17. Kangrga IM and Loewy AD. Whole-cell recordings from visualized C1 adrenergic bulbospinal neurons: Ionic mechanisms underlying vasomotor tone. Brain Res 670: 215-232, 1995.
18. Kobinger W. Central α-adrenergic systems as target for hypotensive drugs. Rev Physiol Biochem Pharmacol 81: 39-100, 1978.
19. Lewis DI and Coote JH. The actions of 5-hydroxytryptamine on the membrane of putative sympatho-excitatory neurones in the rostral ventrolateral medulla of the adult rat in vitro. Brain Res 609: 103-109, 1993.
20. Link RE, Desai K, Hein L, Stevens ME, Chruscinski A, Bernstein D, Barsh GS, and Kobilka BK. Cardiovascular regulation in mice lacking alpha2-adrenergic receptor subtypes b and c. Science 273: 803-805, 1996.
21. Lipski J, Kanjhan R, Kruszewska B, and Rong W. Properties of presympathetic neurones in the rostral ventrolateral medulla in the rat: An intracellular study 'in vivo.' J Physiol (Lond) 490: 729-744, 1996.
22. MacMillan LB, Hein L, Smith MS, Piascik MT, and Limbird LE. Central hypotensive effects of the α2a-adrenergic receptor subtype. Science 273: 801-803, 1996.
23. Milner TA, Morrison SF, Abate C, and Reis DJ. Phenylethanolamine N-methyltransferase-containing terminals synapse directly on sympathetic preganglionic neurons in the rat. Brain Res 448: 205-222, 1988.
24. Milner TA, Rosin DL, Lee A, and Aicher SA. Alpha2A-adrenergic receptors are primarily presynaptic heteroreceptors in the C1 area of the rat rostral ventrolateral medulla. Brain Res 821: 200-211, 1999.
25. Oshima N, Kumagai H, Kawai A, Sakata MK, Matsuura T, and Saruta T. Three types of putative presympathetic neurons in the rostral ventrolateral medulla studied with rat brainstem-spinal cord preparation. Autonom Neurosci 84: 40-49, 2000.
26. Paxinos G and Watson C. The Rat Brain in Stereotaxic Coordinates, 2nd Ed. New York: Academic Press, 1986.
27. Piguet P and Schlichter R. Lability of the pacemaker activity in the rat rostro-ventrolateral medulla: Effects of noradrenaline. Brain Res 796: 1-12, 1998.
28. Prichard BN, Owens CW, and Graham BR. Pharmacology and clinical use of moxonidine, a new centrally acting sympatholytic antihypertensive agent. J Human Hypertens 11: S29-S45, 1997.
29. Reis DJ. Neurons and receptors in the rostroventrolateral medulla mediating the antihypertensive actions of drugs acting at imidazoline receptors. J Cardiovasc Pharmacol 27: S11-S18, 1996.
30. Ruffolo RR, Nichols AJ, Stadel JM, and Hieble JP. Pharmacologic and therapeutic applications of α2-adrenoceptor subtypes. Annu Rev Pharmacol Toxicol 33: 243-279, 1993.
31. Schmitt H, Schmitt H, and Fenard S. Action of α-adrenergic blocking drugs on the sympathetic centres and their interactions with the central sympatho-inhibitory effect of clonidine. Arzneimittel-Forschung 23: 40-45, 1973.
32. Schreihofer AM and Guyenet PG. Role of presympathetic C1 neurons in the sympatholytic and hypotensive effects of clonidine in rats. Am J Physiol 279: R1753-R1762, 2000.
33. Sears TA and Stagg D. Short-term synchronization of intercostal motoneutone activity. J Physiol (Lond) 263: 357-381, 1976.
34. Sun M-K. Central neural organization and control of sympathetic nervous system in mammals. Prog Neurobiol 47: 157-233, 1995.
35. Sun M-K and Guyenet PG. Effects of clonidine and gamma-aminobutyric acid on the discharges of medullo-spinal sympathoexcitatory neurons in the rat. Brain Res 368: 1-17, 1986.
36. Sun M-K and Guyenet PG. Excitation of rostral medullary pacemaker neurons with putative sympathoexcitatory function by cyclic AMP and α-adrenoceptor agonists 'in vitro.' Brain Res 511: 30-40, 1990.
37. Sun M-K, Hackett JT, and Guyenet PG. Sympathoexcitatory neurons of rostral ventrolateral medulla exhibit pacemaker properties in the presence of a glutamate-receptor antagonist. Brain Res 438: 23-40, 1988a.
38. 2+ currents in pacemaker neutones of rat rostral ventrolateral medulla in vitro. J Physiol (Lond) 476: 101-116, 1994.
39. Sun M-K, Young BS, Hackett JT, and Guyenet PG. Reticulospinal pace-maker neurons of the rat rostral ventrolateral medulla with putative sympathoexcitatory function: An intracellular study in vitro. Brain Res 442: 229-239, 1988b.
40. Timmermans PBM, Schoop AMC, Kwa HY, and Van Zwieten PA. Characterization of α-adrenoceptors participating in the central hypotensive and sedative effects of clonidine, using yohimbine, rauwolscine and corynanthine. Eur J Pharmacol 70: 7-15, 1981.
41. Tingley FD and Arneric SP. Evidence for clonidine presynaptically modulating amino acid release in the rostral ventral medulla: role in hypertension. Brain Res 537: 175-181, 1990.
42. Unnerstall JR, Kopajtic TA, and Kuhar MJ. Distribution of α2 agonist binding sites in the rat and human central nervous system: Analysis of some functional, anatomical correlates of the pharmacologic effects of clonidine and related adrenergic agents. Brain Res 319: 69-101, 1984.
43. Van Zwieten PA. Centrally acting antihypertensive drugs. Present and future. Clin Exp Hypertens 21: 859-873, 1999.
44. Winter JC and Rabin RA. Yohimbine as a serotonergic agent: Evidence from receptor binding and drug discrimination. J Pharmacol Exp Ther 263: 682-689, 1992.
45. Yarom Y and Llinas R. Long-term modifiability of anomalous and delayed rectification in guinea pig inferior olivary neurons. J Neurosci 7: 1166-1177, 1987.
46. Zagon A and Smith AD. Monosynaptic projections from the rostral ventrolateral medulla oblongata to identified sympathetic preganglionic neurons. Neuroscience 54: 729-743, 1993.
47. Zagon A and Spyer KM. Stimulation of aortic nerve evokes three different response patterns in neurons of rostral VLM of the rat. Am J Physiol 271: R1720-R1728, 1996.
48. Ziegler D, Haxhiu MA, Kaan EC, Papp JG, and Ernsberger P. Pharmacology of moxonidine, an I1-imidazoline receptor agonist. J Cardiovasc Pharmacol 27: S26-S37, 1996.